Rx News
Critical Alerts For Lowes, Merck, Express Scripts, VMware, and Level 3 Communications Released By InvestorsObserver
September 10, 2013
CHICAGO, IL -- InvestorsObserver issues critical PriceWatch Alerts for LOW, MRK, ESRX, VMW, and LVLT.
Today's PriceWatch Alerts cover the following stocks: Lowes (NYSE: LOW), Merck (NYSE: MRK), Express Scripts (Nasdaq: ESRX), VMware (NYSE: VMW), and Level 3 Communications (NYSE: LVLT).
InvestorsObserver's PriceWatch Alerts contain concise, detailed strategies for each stock we cover, including position protection tactics designed to defend investors from potential market shifts. While many other market reports only provide stock news and opinion, we offer strategies that can bulwark investments against uncertainty and increase chances of making a profit, even if a stock goes down.
"We go above and beyond typical market coverage," said Bobby Raines, Analyst at InvestorsObserver. "Trading experts and beginning investors alike can find value in our PriceWatch Alerts. We provide actionable strategies that protect investments with basic hedging tactics, along with a concise explanation of our techniques."
InvestorsObserver.com is an online newsletter which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help subscribers make the best possible investment decisions.
All stocks and options shown are examples only-- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes--expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors.
News Topics
Top News Articles
- New Parkinson's Disease Drug Approved
May 4, 2017 - Hypertension Guidelines Consensus Statement
April 1, 2017 - Novel Abuse-Deterrent Morphine Approved
March 1, 2017 - New Heart Failure Guidelines
February 1, 2017 - New Eczema Drug Approved
January 1, 2017